These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15504306)

  • 1. [Relationship of peroxisome proliferator-activated receptor with the replication of hepatitis B virus and liver fibrosis].
    Pi B; Tian DY
    Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):636-8. PubMed ID: 15504306
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B virus replication x time equals trouble.
    Perrillo R
    Gastroenterology; 2006 Mar; 130(3):989-91. PubMed ID: 16530534
    [No Abstract]   [Full Text] [Related]  

  • 3. [Peroxisome proliferator-activated receptor in liver diseases].
    Zhao CY; Jiang LL
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jun; 11(6):382-4. PubMed ID: 12837233
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors associated with the intensity of liver fibrosis in renal transplant patients with hepatitis B virus infection.
    Matos CA; Perez RM; Lemos LB; Medina-Pestana JO; Lanzoni VP; Alberto FL; Moreira ES; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):653-7. PubMed ID: 17625434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamivudine treatment of decompensated hepatitis B virus-related cirrhosis.
    Zhang FK
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):10-5. PubMed ID: 16481275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy.
    Liaw YF
    Antivir Ther; 2006; 11(6):669-79. PubMed ID: 17310811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the receptor proteins and transcription factors related to inflammatory bowel diseases].
    Shu DZ; Zhou QX
    Sheng Li Ke Xue Jin Zhan; 2005 Jul; 36(3):269-72. PubMed ID: 16270834
    [No Abstract]   [Full Text] [Related]  

  • 8. [Peroxisome proliferator-activated receptors (PPARs) in obesity and insulin resistance development].
    Alemán G; Torres N; Tovar AR
    Rev Invest Clin; 2004; 56(3):351-67. PubMed ID: 15612519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of hepatitis B virus genotype G coinfected with genotype H in chimeric mice carrying human hepatocytes.
    Tanaka Y; Sanchez LV; Sugiyama M; Sakamoto T; Kurbanov F; Tatematsu K; Roman S; Takahashi S; Shirai T; Panduro A; Mizokami M
    Virology; 2008 Jul; 376(2):408-15. PubMed ID: 18474388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes.
    Sugiyama M; Tanaka Y; Kurbanov F; Maruyama I; Shimada T; Takahashi S; Shirai T; Hino K; Sakaida I; Mizokami M
    Gastroenterology; 2009 Feb; 136(2):652-62.e3. PubMed ID: 19041311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single gene contributions: genetic variants of peroxisome proliferator-activated receptor (isoforms alpha, beta/delta and gamma) and mechanisms of dyslipidemias.
    Yong EL; Li J; Liu MH
    Curr Opin Lipidol; 2008 Apr; 19(2):106-12. PubMed ID: 18388689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus-related cirrhosis: natural history and treatment.
    Chu CM; Liaw YF
    Semin Liver Dis; 2006 May; 26(2):142-52. PubMed ID: 16673292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes.
    Blaschke F; Takata Y; Caglayan E; Law RE; Hsueh WA
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):28-40. PubMed ID: 16239592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signaling.
    Gardner OS; Dewar BJ; Graves LM
    Mol Pharmacol; 2005 Oct; 68(4):933-41. PubMed ID: 16020742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of the fatty acids in ovarian functions: involvement of peroxisome proliferator-activated receptors (PPAR) and adipokines].
    Dupont J; Froment P; Ramé C; Pierre P; Coyral-Castel S; Chabrolle C
    Gynecol Obstet Fertil; 2008 Dec; 36(12):1230-8. PubMed ID: 19013096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptors and inflammation.
    Moraes LA; Piqueras L; Bishop-Bailey D
    Pharmacol Ther; 2006 Jun; 110(3):371-85. PubMed ID: 16168490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.
    Gervois P; Fruchart JC; Staels B
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):145-56. PubMed ID: 17237841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immune response induced by hepatitis B virus principal antigens.
    Huang CF; Lin SS; Ho YC; Chen FL; Yang CC
    Cell Mol Immunol; 2006 Apr; 3(2):97-106. PubMed ID: 16696896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of dual infection of hepatitis B and C viruses among patients with chronic liver disease: a study from tertiary care hospital.
    Chakravarti A; Verma V; Jain M; Kar P
    Trop Gastroenterol; 2005; 26(4):183-7. PubMed ID: 16737047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic syndrome: relationship between insulin sensitivity and the role of peroxisome proliferator-activated receptors (PPARs) in saccharide and lipid metabolism.
    Yahia RB; Lichnovská R; Brychta T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):237-41. PubMed ID: 16601762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.